@dansfera: The pharmaceutical world is on the brink of a major transformation. With clinical trials evolving in real-time—driven by giants like Amgen and AstraZeneca—the industry is testing new models that prioritize speed and precision in rare disease oncology. The real game-changer? The fusion of AI and high-quality data. It’s no longer just about meeting regulatory requirements; it’s about leveraging data as the ultimate asset to revolutionize how drugs are discovered and approved. Within a decade, these innovative trial methods could become the gold standard for medical research everywhere. #Pharma #ClinicalTrials #AIinHealthcare #Biotech #FutureOfMedicine